A review of the metabolic effects of controlled-release Phentermine/Topiramate.

Author: KiortsisDimitrios N

Paper Details 
Original Abstract of the Article :
Very few drugs are approved for obesity treatment by regulatory agencies. Very recently phentermine/topiramate controlled-release [PHEN/TPM CR; (Qsymia®)] obtained Food and Drug Administration (FDA) approval as an addition to a reduced-calorie diet and exercise for chronic weight management. Our aim...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.14310/horm.2002.1438

データ提供:米国国立医学図書館(NLM)

A Camel's Journey Through the Desert of Obesity Treatment

Obesity, a prevalent health concern, is often compared to a vast desert, presenting challenges for both individuals and healthcare professionals. This study delves into the therapeutic landscape of obesity treatment, examining the metabolic effects of controlled-release phentermine/topiramate (PHEN/TPM CR), a medication approved by the FDA for chronic weight management. The authors provide a comprehensive review of the available clinical evidence, evaluating weight loss, metabolic effects, and adverse events associated with this medication. This study underscores the potential benefits and limitations of PHEN/TPM CR as an adjunct to lifestyle modifications in the management of obesity, offering valuable insights for clinicians and patients alike.

Seeking a Sustainable Oasis in the Desert of Obesity

Obesity, like a vast desert, presents challenges in terms of both physical and mental health. This study explores a potential oasis in the form of PHEN/TPM CR, a medication that has shown promising results in weight loss. The study highlights the importance of a multi-pronged approach to managing obesity, combining medication with lifestyle changes to achieve sustainable weight loss.

Navigating the Landscape of Obesity Management: A Camel's Guide

Managing obesity requires a comprehensive approach, taking into account both the physiological and psychological aspects of this complex condition. This study provides valuable insights into the potential benefits and risks of PHEN/TPM CR, guiding clinicians and patients in making informed decisions about treatment options. It is like navigating a vast desert; careful planning and a thoughtful approach are essential to ensure a safe and successful journey.

Dr.Camel's Conclusion

This research provides a valuable roadmap for navigating the complex landscape of obesity treatment. The review of available clinical evidence offers a clear picture of the potential benefits and limitations of PHEN/TPM CR, reminding us that the desert of obesity management requires a multi-pronged approach. Through continued research and a collaborative effort between clinicians and patients, we can continue to find sustainable solutions for managing this complex health challenge.

Date :
  1. Date Completed 2014-09-29
  2. Date Revised 2019-05-07
Further Info :

Pubmed ID

24457398

DOI: Digital Object Identifier

10.14310/horm.2002.1438

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.